The importance of the overexpressed Shh pathway observed in gastric cancer has been demonstrated by the ability of Shh pathway antagonists to suppress growth of gastrointestinal (GI) tumour cell lines and xenografts (Berman et al, 2003; Ma et al, 2005; Ohta et al, 2005). The gene discussed is SHH; the disease is neoplasm.